Speaker biographies

John E. Calfee is a resident scholar at AEI. From 1980 to 1986, he served in the Bureau of Economics at the Federal Trade Commission. Mr. Calfee has taught marketing and consumer behavior in the business schools of the University of Maryland–College Park and Boston University, and was a visiting senior fellow at the Brookings Institution. Mr. Calfee’s research has focused on regulation (especially FDA regulation), health care, advertising and information, tort liability, and other related areas. He is the author of Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Fear of Persuasion: A New Perspective on Advertising and Regulation (AEI Press, 1997).

David L. Gollaher is president and CEO of California Healthcare Institute (CHI), a private, nonprofit public policy research and advocacy organization, which represents California’s leading bioscience companies and academic institutions. Mr. Gollaher joined CHI at its founding in 1993 and was named CEO in 1995. From 1991 to 1994, he served on the faculties of the University of California–San Diego and San Diego State University’s Graduate School of Public Health. Between 1985–1991, Mr. Gollaher was a vice president of Scripps Clinic and Research Foundation, where he was responsible for managed health care, business development, and corporate communications. Earlier in his career, he taught at Harvard University and was an executive with Young & Rubicam in New York. Mr. Gollaher is the author of three books and dozens of articles on the histories of science and medicine, medical ethics, and health policy. As a cofounder of Vision Robotic Corporation, he holds several patents in the field of autonomous robotic navigation. He sits on several foundation and company boards, and presently serves on the State of California Stem Cell Research Advisory Panel.

Mark Pauly is the Bendheim Professor in the Department of Health Care Systems at the Wharton School of the University of Pennsylvania. He is a professor of health care systems, insurance and risk management, and business and public policy at the Wharton School, and is a professor of economics in the School of Arts and Sciences at the University of Pennsylvania. Mr. Pauly is a former commissioner on the Physician Payment Review Commission and an active member of the Institute of Medicine. One of the nation's leading health economists, Mr. Pauly has made significant contributions to the fields of medical economics and health insurance, particularly with respect to reducing the number of uninsured individuals through tax credits for public and private insurance, and appropriate design for Medicare in a budget-constrained environment. Mr. Pauly is a coeditor in chief of the International Journal of Health Care Finance and Economics and an associate editor of the Journal of Risk and Uncertainty. He has served on Institute of Medicine panels on public accountability for health insurers under Medicare and on improving the financing of vaccines. He is an appointed member of the U.S. Department of Health and Human Services National Advisory Committee to the Agency for Healthcare Research and Quality.

Steve Pearson is a general internist and associate professor of ambulatory care and prevention at Harvard Medical School. Dr. Pearson’s work examines the scientific and ethical foundations of evidence-based health care policy. His published work includes the book No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence (Oxford University Press, 2003). Dr. Pearson serves on the management committee of the International Society for Priority Setting in Health Care. In 2004 he was awarded an Atlantic Fellowship to pursue policy studies at the National Institute for Clinical Excellence in London, England. He returned to the United States to serve as special advisor for technology and coverage policy at the Centers for Medicare and Medicaid Services from 2005–2006. In June 2006 he was named senior fellow at America’s Health Insurance Plans, where he performs research and policy analysis on issues related to evidence-based medicine. In 2006 Dr. Pearson also received grant funding to support the Institute for Clinical and Economic Review, a new initiative created to help decision-makers improve the value of health care services through integrated appraisals of the clinical effectiveness and cost effectiveness of medical innovations.

Heinz Redwood works as an independent pharmaceutical and health policy consultant and author. Trained as a scientist, he worked in the British pharmaceutical and chemical industries in commercial development and strategic planning before becoming an independent international consultant. His work focuses on pharmaceutical and health policy, with emphasis on the interface between industry and health care in relation to public policy issues such as pricing and reimbursement, intellectual property rights, patients’ access to medicines, health economics and innovation, and the balance between cost containment in health care and industrial policy. He has published numerous studies on these topics. Mr. Redwood was an expert witness in Ottawa at the Senate of Canada hearings on the repeal of compulsory licensing in 1993, and at the House of Commons Health Committee hearings on the National Health Service Drug Budget in London in 1994. In 2002 and 2003 he was invited by the European Commission to participate as an independent expert in a brainstorming group on access to medicines in developing countries. He has spoken at pharmaceutical and health care seminars and conferences in Austria, Belgium, Brazil, Canada, Denmark, France, Germany, India, Ireland, Japan, Norway, Spain, Sweden, Switzerland, the United Kingdom, and the United States.

Andrea Sutcliffe has a wide-ranging role within the National Institute for Health and Clinical Excellence (NICE) in the UK. She is a qualified accountant and is the institute's chief financial officer. She also has executive director responsibility for the institute’s Patient and Public Involvement Program, human resources, and corporate services. Ms. Sutcliffe leads the development of the institute’s corporate and business plans and coordinates the planning of the institute’s work program and the introduction of new initiatives. She formally acts as the chief executive’s deputy in his absence. Ms. Sutcliffe joined NICE in November 2000 from the London borough of Camden, where she was the assistant director for performance management and resources for the social services department. Prior to her move into local government, she had over thirteen years of experience in health authority and acute and community care settings at the National Health Service of the UK. She has undertaken a variety of roles in finance, business planning, contracting, and general management.

View Event Details